Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

A healthcare provider will examine the skin lesions and, in many cases, determine if the patient has plaque psoriasis. If ...

That’s because certain genes play a role. Psoriasis is a skin disease that affects about 8 million Americans. It comes in several forms. Plaque psoriasis is the most common. Plaque psoriasis ...

Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching among patients with psoriasis ...

Small, drop-like, salmon-pink ... Guttate psoriasis may represent the initial stage of chronic plaque-type psoriasis. On resolution, post-inflammatory hypo or hyperpigmentation may result.

AX-158 has achieved clinical validation through its phase 2a trial for the treatment of patients with mild to moderate plaque ...

Discover a recent study that has investigated the efficacy of excimer light and topical methotrexate 1% hydrogel in managing ...

Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

Topical PF-07038124 showed superior efficacy and safety in treating mild to moderate atopic dermatitis and plaque psoriasis, with significant PASI score improvements. ESK-001, a TYK2 inhibitor ...

Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "Plaque Psoriasis Market by Treatment, by Route of Administration, by End-user, and by Region" report has been added to ResearchAndMarkets.com's offering.